Diabetes Prevention in the Vitamin D and Omega-3 Trial [ANCILLARY OF 700049031]
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 06 Oct 2017
At a glance
- Drugs Colecalciferol (Primary) ; Omega-3-acid ethyl esters (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 15 Apr 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Jun 2015 to 1 Oct 2017.
- 15 Apr 2014 According to the ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.